152 related articles for article (PubMed ID: 30736983)
21. Molecular profiling assays in breast cancer: are we ready for prime time?
Gökmen-Polar Y; Badve S
Oncology (Williston Park); 2012 Apr; 26(4):350-7, 361. PubMed ID: 22655528
[TBL] [Abstract][Full Text] [Related]
22. Implications of genomic instability in the diagnosis and treatment of breast cancer.
Wiechec E
Expert Rev Mol Diagn; 2011 May; 11(4):445-53. PubMed ID: 21545260
[TBL] [Abstract][Full Text] [Related]
23. Gene signatures of genomic instability as prognostic tools for breast cancer.
Sansregret L; Nepveu A
Future Oncol; 2011 May; 7(5):591-4. PubMed ID: 21568672
[No Abstract] [Full Text] [Related]
24. Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer.
Yates LR; Desmedt C
Clin Cancer Res; 2017 Jun; 23(11):2630-2639. PubMed ID: 28572257
[TBL] [Abstract][Full Text] [Related]
25. Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
Rennstam K; Ringberg A; Cunliffe HE; Olsson H; Landberg G; Hedenfalk I
Genes Chromosomes Cancer; 2010 Jan; 49(1):78-90. PubMed ID: 19839046
[TBL] [Abstract][Full Text] [Related]
26. Catalog of genetic progression of human cancers: breast cancer.
Desmedt C; Yates L; Kulka J
Cancer Metastasis Rev; 2016 Mar; 35(1):49-62. PubMed ID: 26951551
[TBL] [Abstract][Full Text] [Related]
27. The Genomic Landscape of Male Breast Cancers.
Piscuoglio S; Ng CK; Murray MP; Guerini-Rocco E; Martelotto LG; Geyer FC; Bidard FC; Berman S; Fusco N; Sakr RA; Eberle CA; De Mattos-Arruda L; Macedo GS; Akram M; Baslan T; Hicks JB; King TA; Brogi E; Norton L; Weigelt B; Hudis CA; Reis-Filho JS
Clin Cancer Res; 2016 Aug; 22(16):4045-56. PubMed ID: 26960396
[TBL] [Abstract][Full Text] [Related]
28. Genomic instability: on the birth and death of cancer.
Murga M; Fernández-Capetillo O
Clin Transl Oncol; 2007 Apr; 9(4):216-20. PubMed ID: 17462973
[TBL] [Abstract][Full Text] [Related]
29. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
[TBL] [Abstract][Full Text] [Related]
31. High-throughput scanning of breast tumor surgical specimens for low-level mutations.
Wang F; Kaur M; Liu WH; Zhu P; Li J; Wang L; Makrigiorgos GM
Clin Chem Lab Med; 2005; 43(8):810-6. PubMed ID: 16201889
[TBL] [Abstract][Full Text] [Related]
32. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions.
Selcuklu SD; Yakicier MC; Erson AE
Cancer Genet Cytogenet; 2009 Feb; 189(1):15-23. PubMed ID: 19167607
[TBL] [Abstract][Full Text] [Related]
33. Molecular Classification of Breast Cancer.
Tsang JYS; Tse GM
Adv Anat Pathol; 2020 Jan; 27(1):27-35. PubMed ID: 31045583
[TBL] [Abstract][Full Text] [Related]
34. Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.
Liang DH; Ensor JE; Liu ZB; Patel A; Patel TA; Chang JC; Rodriguez AA
Breast Cancer Res Treat; 2016 Jan; 155(1):139-49. PubMed ID: 26667234
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic changes in BRCA1-mutated familial breast cancer.
Downs B; Wang SM
Cancer Genet; 2015 May; 208(5):237-40. PubMed ID: 25800897
[TBL] [Abstract][Full Text] [Related]
36. [Tumour genomics: an unstable landscape].
Moyret-Lalle C; Falette N; Grelier G; Puisieux A
Bull Cancer; 2008 Oct; 95(10):923-30. PubMed ID: 19004721
[TBL] [Abstract][Full Text] [Related]
37. Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
Santa-Maria CA; Kruse M; Raska P; Weiss M; Swoboda A; Mutonga MB; Abraham J; Jain S; Nanda R; Montero AJ
Breast Cancer Res Treat; 2017 Nov; 166(1):179-184. PubMed ID: 28752189
[TBL] [Abstract][Full Text] [Related]
38. Genomic and epigenomic cross-talks in the regulatory landscape of miRNAs in breast cancer.
Samantarrai D; Dash S; Chhetri B; Mallick B
Mol Cancer Res; 2013 Apr; 11(4):315-28. PubMed ID: 23360796
[TBL] [Abstract][Full Text] [Related]
39. The genomic landscape of breast cancer and its interaction with host immunity.
Luen S; Virassamy B; Savas P; Salgado R; Loi S
Breast; 2016 Oct; 29():241-50. PubMed ID: 27481651
[TBL] [Abstract][Full Text] [Related]
40. Genomic instability in the breast microenvironment? A critical evaluation of the evidence.
Holliday C; Rummel S; Hooke JA; Shriver CD; Ellsworth DL; Ellsworth RE
Expert Rev Mol Diagn; 2009 Oct; 9(7):667-78. PubMed ID: 19817552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
